We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » First U.S. Clinical Trial of a COVID-19 Treatment Begins
First U.S. Clinical Trial of a COVID-19 Treatment Begins
The first U.S. clinical trial of a treatment for COVID-19 — Gilead’s antiviral remdesivir — has begun at the University of Nebraska Medical Center in Omaha.